ResearchDx , the Leading Contract Diagnostics Organization, Completes Their Expansion Into a New Facility

IRVINE, Calif., July 22, 2013 /PRNewswire/ -- ResearchDx, LLC of Irvine, California today is pleased to announce the purchase, build-out and relocation to our state of the art 30,000 sq. foot facility in Irvine California. The custom designed facility will support our continued expansion of in vitro diagnostic (IVD) development services to the pharmaceutical, biotechnology, diagnostic development and clinical laboratory industries.

To celebrate this event, ResearchDx will be holding an open house on July 23 from 1-7pm. The event is open to anyone with a professional or personal interest in diagnostics and diagnostic development. Laboratory tours and technology presentations will be conducted throughout the afternoon, and food and beverages will be served. For more information regarding this event please contact Natalie McCan: nmccan@researchdx.com.

New health care initiatives toward personalized medicine and the corresponding need for IVD tests to come to market alongside pharmaceuticals as Companion Diagnostics (CDx) is indeed changing the way drug companies target diseases and treatments for patients. ResearchDx believes in this new approach to drug development and is committed to helping their clients advance their IVD / CDx to market with regulatory approval faster and more effectively than a company's own internal resources or other partnerships may allow. Through their support in developing these more patient targeted therapies, ResearchDx is helping to get the right drug to the right patient the first time to improve patient care and reduce overall healthcare costs. The expansion will create more space for more projects and more approvals in the end to help more patients.

ResearchDx is the leading Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. The company provides comprehensive, integrated, flexible services for the in vitro diagnostic development process. From initial assay conceptualization, discovery, optimization and validation in a CAP/CLIA laboratory environment, through a complete set of clinical research services and on to regulatory approval, ResearchDx offers the services and solutions to meet complex diagnostics development needs. ResearchDx's primary service areas include assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and consulting. Additional information is available at www.researchdx.com.

Media Contact:

Philip D. Cotter, PhD, FACMG, FFSc(RCPA)
ResearchDx
5 Mason, Suite 100
Irvine, CA 92618
pcotter@researchdx.com
866-225-9195 / 510-332-0477

SOURCE ResearchDx